Alight (ALIT) Q2 2026 Earnings Call Transcript

Alight (ALIT) reported Q2 revenue of $511M (-3.2% YoY) with recurring revenue down to $471M (-4.3%), but adjusted EBITDA of $92M (18% margin) exceeded expectations. The company cut adjusted EPS to $0.91 from $2.09 in Q2 2025 and guided 2026 revenue to $2.078B–$2.098B and adjusted EBITDA to $400M–$415M, with Q3 EBITDA of $55M–$61M reflecting seasonal annual-enrollment investment. Liquidity remains solid at $545M (including $215M cash and a $330M undrawn revolver) and free cash flow was $48M in Q2 ($101M YTD), with full-year FCF conversion guided at 40%–43% of adjusted EBITDA; management also eliminated its dividend to preserve capital flexibility while evaluating buybacks/debt leverage.

Analysis

ALIT reads like a delayed-turnaround story where the market is being asked to underwrite 2027-28 benefits from initiatives that are still mostly in the pilot/rollout phase. The key mechanism is that service insourcing and AI can improve retention and implementation efficiency, but they do not fix the near-term earnings bridge because the revenue base is still rolling through prior renewal decisions. That makes current-quarter beats low-quality for valuation: better flow-through can coexist with structurally weaker recurring revenue and a levered balance sheet.

The bigger winner is not ALIT equity; it is adjacent, better-capitalized workflow and outsourcing names that can absorb any share loss if clients decide to de-risk vendor concentration. ADP and PAYX are the cleaner public proxies for HR-processing resilience, while AON and MMC benefit if employer clients shift more benefit-adjacent work toward integrated intermediaries rather than pure-play administration. On the flip side, the stock is vulnerable to any stumble in service quality because leverage leaves less room for a prolonged revenue gap; the dividend cut helps liquidity, but it also removes a support under the equity.

The contrarian case is that the market may be too dismissive of the renewal lag: if the operational changes are real, the P&L inflection could arrive faster than the sell-side expects once 2025 cohorts roll off. But the burden of proof is high, and the first falsifier is continued recurring-revenue erosion into Q4 plus no visible improvement in conversion of pipeline to signed renewals. Until then, this looks like a hold-to-sell-on-strength, not an immediate long, because the upside is deferred while the downside is visible over the next 1-2 quarters.

Key Decisions for Investors

• Avoid initiating a new long in ALIT here; wait for one more quarter of proof that recurring revenue has stabilized and that Q3 cash drag does not force balance-sheet prioritization. Time horizon: 1-2 quarters.
• If ALIT rallies on the 2027-28 transformation narrative, consider a 3-6 month bearish options structure (put spread) rather than outright shorting; the thesis depends on near-term execution slippage and leverage sensitivity, not a collapse in the business. Best entry is on post-earnings strength.
• Relative-value: long ADP / short ALIT as a quality-vs-turnaround pair. ADP should retain multiple support if the market rotates toward durable cash conversion, while ALIT remains a self-help story with delayed realization. Horizon: 3-6 months.
• Monitor ALIT for a genuine inflection trigger: recurring revenue stabilization, explicit buyback authorization, or net leverage improvement without sacrificing reinvestment. Any one of those would materially weaken the short case.
• Watch AON and MMC as secondary beneficiaries if employer clients become more skeptical of standalone benefits administrators; any evidence of vendor consolidation or renewal friction at ALIT would be a positive read-through for these intermediaries.